Amygdala connectivity predicts response to ketamine treatment in patients with anxiety depression
A region of the brain known as the amygdala may play a key role in predicting symptom improvement after ketamine treatment in patients with treatment-resistant anxiety depression Journal of Affective Disorders. “Since the antidepressant effects of ketamine in patients with anxiety depression remain uncertain, there is a need to investigate potential biomarkers predicting the antidepressant …